Artiva Biotherapeutics, Common Stock Buy Hold or Sell Recommendation
| ARTV Stock | 11.04 0.64 6.15% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Artiva Biotherapeutics, Common is 'Cautious Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Artiva Biotherapeutics, Common given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Artiva Biotherapeutics, Common, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Artiva Biotherapeutics, Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Artiva and provide practical buy, sell, or hold advice based on investors' constraints. Artiva Biotherapeutics, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Artiva |
Execute Artiva Biotherapeutics, Buy or Sell Advice
The Artiva recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Artiva Biotherapeutics, Common. Macroaxis does not own or have any residual interests in Artiva Biotherapeutics, Common or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Artiva Biotherapeutics,'s advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Artiva Biotherapeutics, Trading Alerts and Improvement Suggestions
| Artiva Biotherapeutics, had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 33.49 M. Net Loss for the year was (28.72 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Artiva Biotherapeutics, generates negative cash flow from operations | |
| Artiva Biotherapeutics, has a frail financial position based on the latest SEC disclosures | |
| Over 89.0% of the company shares are held by institutions such as insurance companies |
Artiva Biotherapeutics, Returns Distribution Density
The distribution of Artiva Biotherapeutics,'s historical returns is an attempt to chart the uncertainty of Artiva Biotherapeutics,'s future price movements. The chart of the probability distribution of Artiva Biotherapeutics, daily returns describes the distribution of returns around its average expected value. We use Artiva Biotherapeutics, Common price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Artiva Biotherapeutics, returns is essential to provide solid investment advice for Artiva Biotherapeutics,.
| Mean Return | 0.40 | Value At Risk | -10.48 | Potential Upside | 10.28 | Standard Deviation | 6.72 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Artiva Biotherapeutics, historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Artiva Biotherapeutics, Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Artiva Biotherapeutics, or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Artiva Biotherapeutics,'s price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Artiva stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.38 | |
β | Beta against Dow Jones | 0.71 | |
σ | Overall volatility | 6.59 | |
Ir | Information ratio | 0.06 |
Artiva Biotherapeutics, Volatility Alert
Artiva Biotherapeutics, Common is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Artiva Biotherapeutics,'s stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Artiva Biotherapeutics,'s stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Artiva Biotherapeutics, Fundamentals Vs Peers
Comparing Artiva Biotherapeutics,'s fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Artiva Biotherapeutics,'s direct or indirect competition across all of the common fundamentals between Artiva Biotherapeutics, and the related equities. This way, we can detect undervalued stocks with similar characteristics as Artiva Biotherapeutics, or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Artiva Biotherapeutics,'s fundamental indicators could also be used in its relative valuation, which is a method of valuing Artiva Biotherapeutics, by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Artiva Biotherapeutics, to competition |
| Fundamentals | Artiva Biotherapeutics, | Peer Average |
| Return On Equity | -0.44 | -0.31 |
| Operating Margin | (23.45) % | (5.51) % |
| Current Valuation | 136.49 M | 16.62 B |
| Shares Outstanding | 24.29 M | 571.82 M |
| Shares Owned By Insiders | 20.64 % | 10.09 % |
| Shares Owned By Institutions | 89.07 % | 39.21 % |
| Number Of Shares Shorted | 1.03 M | 4.71 M |
| Price To Book | 1.33 X | 9.51 X |
| Price To Sales | 103.10 X | 11.42 X |
| Revenue | 33.49 M | 9.43 B |
| EBITDA | (28.41 M) | 3.9 B |
| Net Income | (28.72 M) | 570.98 M |
| Total Debt | 16.91 M | 5.32 B |
| Book Value Per Share | 8.28 X | 1.93 K |
| Cash Flow From Operations | (47.43 M) | 971.22 M |
| Short Ratio | 20.47 X | 4.00 X |
| Earnings Per Share | (2.48) X | 3.12 X |
| Target Price | 21.25 | |
| Number Of Employees | 82 | 18.84 K |
| Market Capitalization | 268.15 M | 19.03 B |
| Total Asset | 105.11 M | 29.47 B |
| Retained Earnings | (181.31 M) | 9.33 B |
| Working Capital | 67.59 M | 1.48 B |
| Net Asset | 105.11 M |
Note: Insider Trading [view details]
Artiva Biotherapeutics, Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Artiva . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Artiva Biotherapeutics, Buy or Sell Advice
When is the right time to buy or sell Artiva Biotherapeutics, Common? Buying financial instruments such as Artiva Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Artiva Biotherapeutics, in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Compulsion Thematic Idea Now
Compulsion
Companies involved in research, development, and manufacturing of products with compulsion characteristics such as cigarettes, addictive drugs and alcohol. The Compulsion theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Compulsion Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Artiva Stock Analysis
When running Artiva Biotherapeutics,'s price analysis, check to measure Artiva Biotherapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Artiva Biotherapeutics, is operating at the current time. Most of Artiva Biotherapeutics,'s value examination focuses on studying past and present price action to predict the probability of Artiva Biotherapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Artiva Biotherapeutics,'s price. Additionally, you may evaluate how the addition of Artiva Biotherapeutics, to your portfolios can decrease your overall portfolio volatility.